Projects funded by the NCN

DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr hab. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

Call: OPUS 24 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

Uczelnia Łazarskiego

RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Mikołaj Czajkowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

Call: OPUS 19 , Panel: NZ7

Principal investigator: prof. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy wit...

Call: PRELUDIUM 16 , Panel: NZ5

Principal investigator: Joanna Knap-Stępień

Uniwersytet Medyczny w Lublinie, Wydział Lekarski

Personalized therapy - design and verification of the optimalization and manufacturing of the modified release, orally t...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Sebastian Polak

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

MicroRNAs in blood as biomarkers for Alzheimer's disease: molecular signature for personalized therapy

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Urszula Wojda

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

Breath gas Analysis for Detection of Ventilation-Associated Pneumoania and monitoring of personalized therapy (BAD-VAP).

Call: SONATA 13 , Panel: NZ6

Principal investigator: dr Wojciech Filipiak

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy